Skip Navigation

Cardiovascular Research 2001 49(4):713-720; doi:10.1016/S0008-6363(00)00309-6
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Burgdorf, C.
Right arrow Articles by Richardt, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Burgdorf, C.
Right arrow Articles by Richardt, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Adenosine inhibits norepinephrine release in the postischemic rat heart: the mechanism of neuronal stunning

Christof Burgdorfa, Doreen Richardta, Thomas Kurza, Melchior Seyfarthb, Deepak Jaina, Hugo A. Katusa and Gert Richardta,*

aMedizinische Klinik II, Universitätsklinikum Lübeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
bDeutsches Herzzentrum München, Munich, Germany

* Corresponding author. Tel.: +49-451-500-2420; fax: +49-451-500-6437 gert.richardt{at}medinf.mu-luebeck.de

Objective: Numerous studies support the concept of impaired postischemic sympathetic neurotransmission in the heart. We hypothesized that postischemic neuronal dysfunction (neuronal stunning) is caused by a transient suppression of exocytotic norepinephrine (NE) release from sympathetic nerve terminals. Furthermore, we assessed the role of presynaptic adenosine-receptors and {alpha}2-adrenoceptors in neuronal stunning. Methods and results: Exocytotic NE release was induced by two electrical field stimulations (S1 and S2) in isolated perfused rat hearts. S1 was performed under baseline conditions and S2 either during or following intervention. Results are expressed as mean S2/S1 ratios±S.E.M. Stepwise increase of global ischemic periods (10, 20, and 30 min) induced a progressive suppression of NE release in the postischemic hearts, which was reversible during reperfusion. Both the degree and duration of NE suppression was dependent on the extent of the preceding ischemic period. Following 10-min ischemia complete recovery of NE release was achieved after 5-min reperfusion (1.07±0.12), whereas 5-min reperfusion did not restore NE release after 30 min (0.36±0.07) of ischemia. The adenosine-receptor antagonists 8-phenyltheophylline (8-PT; non-selective) and 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; adenosine A1-receptor subtype selective) significantly increased NE release after 30-min ischemia and 5-min reperfusion (0.78±0.06 and 0.64±0.07), while in the same experimental protocol blockade of {alpha}2-adrenoceptors by yohimbine failed to restore the postischemic release (0.24±0.06). In non-ischemic hearts the adenosine analogue R(–)N6-(2-phenylisopropyl)adenosine (R-PIA) resulted in a marked suppression of NE release (0.61±0.07). The inhibitory effect of R-PIA and 2-chloro-N6-cyclopentyladenosine (CCPA; adenosine A1-receptor subtype selective agonist) persisted 5 min after cessation of R-PIA (0.62±0.05) and CCPA (0.58±0.04). Activation of {alpha}2-adrenoceptors by 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine (UK 14,304) also caused a reduction of NE release (0.50±0.02), but the release increased to control levels 5 min after cessation of UK 14,304 (0.90±0.06). Conclusions: The results establish the phenomenon of neuronal stunning in terms of a postischemic suppression of exocytotic NE release and provide evidence that neuronal stunning is mediated by endogenous adenosine through activation of presynaptic adenosine A1-receptors.

KEYWORDS Adenosine; Adrenergic (ant)agonists; Ischemia; Reperfusion; Neurotransmitters


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
M. Podgorska, K. Kocbuch, M. Grden, A. Szutowicz, and T. Pawelczyk
Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters
J. Physiol., October 1, 2006; 576(1): 179 - 189.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Linden
Adenosine in Tissue Protection and Tissue Regeneration
Mol. Pharmacol., May 1, 2005; 67(5): 1385 - 1387.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Burgdorf, A. Dendorfer, T. Kurz, E. Schomig, I. Stolting, F. Schutte, and G. Richardt
Role of Neuronal KATP Channels and Extraneuronal Monoamine Transporter on Norepinephrine Overflow in a Model of Myocardial Low Flow Ischemia
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 42 - 48.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, B. Hack, and K. J. Ashton
Acute adenosinergic cardioprotection in ischemic-reperfused hearts
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Boehm and H. Kubista
Fine Tuning of Sympathetic Transmitter Release via Ionotropic and Metabotropic Presynaptic Receptors
Pharmacol. Rev., March 1, 2002; 54(1): 43 - 99.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Stangl, G. Baumann, K. Stangl, and S. B Felix
Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion
Cardiovasc Res, January 1, 2002; 53(1): 12 - 30.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Pernow
Adenosine as an important mediator of post-ischaemic neuronal stunning
Cardiovasc Res, March 1, 2001; 49(4): 693 - 694.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.